Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

The legal marijuana industry is still in the early stages, so let's see if investors should consider buying some pure-play marijuana stocks heading into earnings.

Buy Marijuana Stocks, Tilray & Aurora Cannabis, Before Earnings?

Compared to other marijuana stocks, Tilray stock looks disappointing. But a strategy change might make TLRY stock the most attractive now.

Why Tilray Stock Could Be the Best Pick Among Marijuana Names

Tilray Inc. announced Wednesday that it has invested $32.6 million to increase its Canadian cannabis production and manufacturing.

Tilray Announces $32.6M Investment In Canadian Cannabis Operations

Aphria

Two of the most popular marijuana stocks face-planted last month.

The 5 Worst-Performing Pot Stocks in April

Canopy Growth

Cronos Group

GW Pharmaceuticals

Two marijuana stocks currently have at least $1.8 billion in cash and cash equivalents at their disposal.

These 5 Pot Stocks Have the Most Cash

CannTrust Holdings

HEXO Corp

If you're hunting pot stocks with the best chance of turning rising sales into shareholder profit, you ought to consider these stocks.

These Top Marijuana Stocks Have the Best Profit Margin

High Park Holdings, a wholly owned subsidiary of Tilray, Inc., announced Monday that it has received an amendment to the company's standard processing license under the Canadian Cannabis Ac.

Tilray's High Park Expands Supply Capacity With Amended License

Curaleaf Holdings, Inc.

MedMen Enterprises Inc.

Trulieve Cannabis Corp.

You'll find plenty of growers and dispensary operators among the largest marijuana stocks.

Meet Marijuana's 14 Billion-Dollar Pot Stocks

Voluntary lockup agreements may have saved the day in the first half of the year, but insiders could look to sell in the months that lie ahead.

3 Pot Stocks Facing Huge Lockup Expirations in the Second Half of 2019

Scotts Miracle-Gro

Cannabis stocks had a huge showing on Wall Street this past fall.

Short Sellers Hazy on Picking Cannabis Stocks

Can his marijuana company's stock make you rich, too?

This Marijuana CEO Made 18 Times More Than the Richest Man in the World Last Year

Perrigo

Molson Coors Brewing

Cannabis companies remain "trader" stocks.

Cannabis Stocks: The Massive Gap Between Fact And Fantasy

Constellation Brands

These companies have the highest debt levels in the cannabis industry. But there's more to the story.

5 Marijuana Stocks With the Most Debt: Should Investors Be Worried?

Green Thumb Industries Inc.

There are some surprising marijuana stocks at the top and bottom of this list.

Which Pot Stocks Have the Highest Gross Margin?

Nearly every candidate support federal legalization of recreational marijuana and many call for expunging federal charges for those prosecuted.

Most 2020 Democratic presidential candidates agree on recreational marijuana: Legalize it

The world is "going green" at an increasingly rapid pace.

16 Marijuana 4/20 Facts That Show How Far the Cannabis Movement Has Come

Canopy Growth's next quarterly update might not be nearly as rosy as its last one. And the situation could be even worse for other marijuana producers.

Why 1 Analyst Just Slashed Revenue Estimates for Canopy Growth -- and What It Could Mean for Other Marijuana Stocks

Without a company name attached to these metrics, are pot stocks really an attractive investment opportunity?

Can You Guess the Identity of These Marijuana Stocks?

Quest Diagnostics' Drug Testing Index highlights a potentially worrisome trend.

Should We Blame Marijuana for a 14-Year High in Positive Work-Related Drug Tests?

Profits could be a lot tougher to come by than investors realize.

Earnings Estimates Are Tumbling for These Pot Stocks

Two out of three Americans favor legalizing marijuana. So, why hasn't that happened yet?

Why Is Legalizing Pot Proving So Difficult in the United States?

For the second time in 2.5 months, two executives at this popular marijuana stock have lightened their respective stakes.

Uh-Oh! Insiders of This Pot Stock Are Selling Again

Cannabis stocks had a huge showing on Wall Street this past fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them. Some of the stocks even doubled or tripled in value in this time.

Short Sellers Getting Higher on Cannabis Stocks

On Oct. 17, 2018, Canada made history by becoming the first G7 country and the second country overall to legalize adult-use cannabis.

Study Says Canadian Cannabis Market Could Reach $5.2B By 2024: 4 Provinces To Watch

These brand-name pot stocks have some pretty glaring deficiencies.

News for Tilray Brands Stock (TLRY)